NYSE:FMS - Fresenius Medical Care Stock Price, Price Target & More

Get Started

$50.85 -0.36 (-0.70 %)

(As of 05/22/2018 12:02 PM ET)

Previous Close$51.02

Today's Range$50.82 - $51.05

52-Week Range$44.88 - $57.94

Volume2,299 shs

Average Volume146,795 shs

Market Capitalization$31.57 billion

P/E Ratio23.09

Dividend YieldN/A

Beta0.62

About Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.

Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified

Sub-IndustryN/A

SectorMedical

SymbolNYSE:FMS

CUSIPN/A

Webwww.freseniusmedicalcare.com

Phone49-6172-6090

Debt

Debt-to-Equity Ratio0.53

Current Ratio1.26

Quick Ratio1.01

Price-To-Earnings

Trailing P/E Ratio23.09

Forward P/E Ratio19.33

P/E Growth2.79

Sales & Book Value

Annual Sales$20.09 billion

Price / Sales1.55

Cash Flow$3.5288 per share

Price / Cash14.41

Book Value$19.97 per share

Price / Book2.55

Profitability

EPS (Most Recent Fiscal Year)$2.21

Net Income$1.45 billion

Net Margins7.29%

Return on Equity11.09%

Return on Assets4.92%

Miscellaneous

Employees114,000

Outstanding Shares612,900,000

Fresenius Medical Care (NYSE:FMS) Frequently Asked Questions

What is Fresenius Medical Care's stock symbol?

Fresenius Medical Care trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

How often does Fresenius Medical Care pay dividends? What is the dividend yield for Fresenius Medical Care?

Fresenius Medical Care announced an annual dividend on Thursday, May 10th. Shareholders of record on Tuesday, May 22nd will be given a dividend of $0.436 per share on Monday, June 4th. This represents a yield of 0.86%. The ex-dividend date of this dividend is Monday, May 21st. View Fresenius Medical Care's Dividend History.

How were Fresenius Medical Care's earnings last quarter?

Fresenius Medical Care (NYSE:FMS) announced its quarterly earnings results on Thursday, May, 3rd. The company reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.70 by $0.21. The business earned $3.98 billion during the quarter, compared to analysts' expectations of $4.07 billion. Fresenius Medical Care had a net margin of 7.29% and a return on equity of 11.09%. The company's revenue was down 12.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.01 earnings per share. View Fresenius Medical Care's Earnings History.

When is Fresenius Medical Care's next earnings date?

Fresenius Medical Care is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Fresenius Medical Care.

What price target have analysts set for FMS?

7 brokerages have issued twelve-month price targets for Fresenius Medical Care's shares. Their forecasts range from $44.00 to $62.00. On average, they anticipate Fresenius Medical Care's stock price to reach $53.00 in the next year. View Analyst Ratings for Fresenius Medical Care.

Who are some of Fresenius Medical Care's key competitors?

Some companies that are related to Fresenius Medical Care include DaVita (DVA), Tivity Health (TVTY), American Renal Associates (ARA), Catasys (CATS), Caladrius Biosciences (CLBS), CNS Response (MYND), BioRestorative Therapies (BRTX), Pacific Health Care Organization (PFHO), Hooper Holmes (HPHW) and American Caresource (GNOW).

Who are Fresenius Medical Care's key executives?

Fresenius Medical Care's management team includes the folowing people:

Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 63)
Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 63)
Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 59)
Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 46)
Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 56)

Has Fresenius Medical Care been receiving favorable news coverage?

Media coverage about FMS stock has trended somewhat positive on Tuesday, according to Accern Sentiment. The research group rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Fresenius Medical Care earned a media sentiment score of 0.18 on Accern's scale. They also assigned headlines about the company an impact score of 45.49 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Who are Fresenius Medical Care's major shareholders?

Fresenius Medical Care's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Northern Trust Corp (0.13%), Royal Bank of Canada (0.10%), Thornburg Investment Management Inc. (0.06%), US Bancorp DE (0.05%), Allianz Asset Management GmbH (0.05%) and Aperio Group LLC (0.04%). View Institutional Ownership Trends for Fresenius Medical Care.

Which institutional investors are selling Fresenius Medical Care stock?

FMS stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Boston Partners, US Bancorp DE, Bbva Compass Bancshares Inc., Allianz Asset Management GmbH, A.R.T. Advisors LLC, Intrust Bank NA and Cubist Systematic Strategies LLC. View Insider Buying and Selling for Fresenius Medical Care.

Which institutional investors are buying Fresenius Medical Care stock?

FMS stock was acquired by a variety of institutional investors in the last quarter, including Thornburg Investment Management Inc., Millennium Management LLC, Sivik Global Healthcare LLC, Royal Bank of Canada, Barclays PLC, Wells Fargo & Company MN, Aperio Group LLC and Northern Trust Corp. View Insider Buying and Selling for Fresenius Medical Care.

How do I buy shares of Fresenius Medical Care?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fresenius Medical Care's stock price today?

One share of FMS stock can currently be purchased for approximately $50.84.

How big of a company is Fresenius Medical Care?

Fresenius Medical Care has a market capitalization of $31.57 billion and generates $20.09 billion in revenue each year. The company earns $1.45 billion in net income (profit) each year or $2.21 on an earnings per share basis. Fresenius Medical Care employs 114,000 workers across the globe.

How can I contact Fresenius Medical Care?

Fresenius Medical Care's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-6090 or via email at [email protected]

MarketBeat Community Rating for Fresenius Medical Care (FMS)

Community Ranking:		2.0 out of 5 ( )
Outperform Votes:		217 (Vote Outperform)
Underperform Votes:		321 (Vote Underperform)
Total Votes:		538

MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care and other stocks. Vote "Outperform" if you believe FMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Fresenius Medical Care (NYSE:FMS) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

7 Wall Street analysts have issued ratings and price targets for Fresenius Medical Care in the last 12 months. Their average twelve-month price target is $53.00, suggesting that the stock has a possible upside of 4.23%. The high price target for FMS is $62.00 and the low price target for FMS is $44.00. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Hold
Consensus Rating Score:	2.57	2.50	2.50	2.43
Ratings Breakdown:	0 Sell Rating(s) 3 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 4 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 2 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$53.00	$53.00	$53.00	$44.00
Price Target Upside:	4.23% upside	5.58% upside	0.68% upside	9.13% downside

Fresenius Medical Care (NYSE:FMS) Consensus Price Target History

Price Target History for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE:FMS) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/3/2018	Royal Bank of Canada	Reiterated Rating	Neutral		Low
4/24/2018	Deutsche Bank	Upgrade	Hold ➝ Buy		Low
4/23/2018	DZ Bank	Reiterated Rating	Buy		High
1/4/2018	UBS	Upgrade	Sell ➝ Neutral		Low
1/2/2018	Nord/LB	Reiterated Rating	Buy		Low
12/21/2017	SunTrust Banks	Set Price Target	Buy	$62.00	Low
12/11/2017	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight		Low
3/12/2017	Sanford C. Bernstein	Reiterated Rating	Buy		Low
2/24/2017	Societe Generale	Downgrade	Buy ➝ Hold		N/A
12/14/2016	JPMorgan Chase	Reiterated Rating	Buy		N/A
10/18/2016	Citigroup	Reiterated Rating	Buy		N/A
9/21/2016	Goldman Sachs	Reiterated Rating	Buy		N/A
8/9/2016	Berenberg Bank	Reiterated Rating	Buy		N/A
7/8/2016	Jefferies Group	Upgrade	Underperform ➝ Hold		N/A

(Data available from 5/22/2016 forward)

Fresenius Medical Care (NYSE:FMS) Earnings History and Estimates Chart

Earnings by Quarter for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE:FMS) Earnings Estimates

2018 EPS Consensus Estimate: $2.57

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.61	$0.61	$0.61
Q2 2018	1	$0.64	$0.64	$0.64
Q3 2018	1	$0.66	$0.66	$0.66
Q4 2018	1	$0.66	$0.66	$0.66
Q1 2019	1	$0.67	$0.67	$0.67
Q2 2019	1	$0.69	$0.69	$0.69
Q3 2019	1	$0.70	$0.70	$0.70

Fresenius Medical Care (NYSE FMS) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/7/2018
5/3/2018	3/31/2018	$0.70	$0.49	$4.0674 billion	$3.9760 billion	View	N/A
2/26/2018	Q4 2017	$0.61	$0.69	$5.3703 billion	$5.2160 billion	View	N/A
11/2/2017	Q3 2017	$0.61	$0.59	$5.3643 billion	$5.0932 billion	View	N/A
8/1/2017	6/30/2017	$0.53	$0.48	$5.2028 billion	$4.4710 billion	View	Listen
5/3/2017	Q2	$0.44	$0.53	$4.6874 billion	$4.5480 billion	View	Listen
2/22/2017	Q416	$0.62	$0.63	$4.74 billion	$4.6870 billion	View	Listen
10/27/2016	Q316	$0.52	$0.54	$4.55 billion	$4.5980 billion	View	Listen
8/1/2016	Q216	$0.49	$0.48	$4.54 billion	$4.42 billion	View	N/A
5/3/2016	Q116	$0.42	$0.37	$4.25 billion	$4.2050 billion	View	N/A
2/24/2016	Q415	$0.58	$0.52	$4.41 million	$4.35 million	View	Listen
10/29/2015	Q3	$0.45	$0.43	$4.2749 billion	$4.2310 billion	View	Listen
7/30/2015	Q215	$0.42	$0.40	$4.13 billion	$4.1990 billion	View	Listen
4/30/2015	Q1	$0.40	$0.35	$3.8873 billion	$3.96 billion	View	N/A
2/25/2015	Q4	$0.49	$0.56	$4.2301 billion	$4.32 billion	View	N/A
11/4/2014	Q3	$0.44	$0.45	$3.9443 billion	$4.1130 billion	View	N/A
7/31/2014	Q2	$0.41	$0.39		$3.8350 billion	View	N/A
5/6/2014	Q1 2014	$0.38	$0.34	$3.6045 billion	$3.5640 billion	View	N/A
2/25/2014	Q4	$0.53	$0.58	$3.8464 billion	$3.8670 billion	View	N/A
11/5/2013		$0.45	$0.47	$3.6427 billion	$3.6661 billion	View	N/A
7/30/2013		$0.46	$0.43	$3.6147 billion	$3.6125 billion	View	N/A
4/30/2013	Q1 2013	$0.45	$0.37	$3.4997 billion	$3.4639 billion	View	N/A
2/26/2013	Q4 2012	$0.52	$1.07			View	N/A
10/31/2012	Q3 2012	$0.49	$0.22			View	N/A
8/1/2012	Q2 2012	$0.46	$0.44			View	N/A
5/3/2012	Q1 2012	$0.42	$0.40			View	N/A
2/21/2012	Q4 2011	$0.51	$0.51			View	N/A
11/3/2011	Q3 2011	$0.47	$0.46			View	N/A
8/2/2011	Q2 2011	$0.43	$0.43			View	N/A
5/4/2011	Q1 2011	$0.38	$0.37			View	N/A
2/23/2011	Q4 2010	$0.44	$0.45			View	N/A
11/2/2010	Q3 2010	$0.42	$0.41			View	N/A
8/3/2010	Q2 2010	$0.40	$0.42			View	N/A
5/4/2010	Q1 2010	$0.37	$0.35			View	N/A
2/24/2010	Q4 2009	$0.40	$0.41			View	N/A
11/3/2009	Q3 2009	$0.38	$0.38			View	N/A
8/4/2009	Q2 2009	$0.37	$0.37			View	N/A
4/30/2009	Q1 2009	$0.33	$0.34			View	N/A
2/19/2009	Q4 2008	$0.36	$0.36			View	N/A
11/4/2008	Q3 2008	$0.35	$0.35			View	N/A
7/30/2008	Q2 2008	$0.34	$0.36			View	N/A
4/30/2008	Q1 2008	$0.31	$0.32			View	N/A
2/20/2008	Q4 2007	$0.31	$0.34			View	N/A

(Earnings results data provided by Zacks Investment Research)

Fresenius Medical Care (NYSE:FMS) Dividend Information

Fresenius Medical Care pays an annual dividend of $0.37 per share, with a dividend yield of 0.73%. FMS's next annual dividend payment will be made on Monday, June 4. The company has grown its dividend for the last 2 consecutive years and is increasing its dividend by an average of 0.20% each year. Fresenius Medical Care pays out 16.74% of its earnings out as a dividend.

Next Dividend:	6/4/2018
Annual Dividend:	$0.37
Dividend Yield:	0.73%
Dividend Growth:	0.20% (3 Year Average)
Payout Ratio(s):	16.74% (Trailing 12 Months of Earnings) 14.07% (Based on This Year's Estimates) 12.98% (Based on Next Year's Estimates) 10.49% (Based on Cash Flow)
Track Record:	2 Years of Consecutive Dividend Growth

Dividend Payments by Quarter for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE:FMS) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/10/2018	Annual	$0.4360	0.86%	5/21/2018	5/22/2018	6/4/2018
4/24/2017	annual	$0.5137	1.17%	5/11/2017	5/15/2017	5/26/2017
3/9/2016		$0.3040		5/10/2016	5/12/2016	5/23/2016
5/2/2014	annual	$0.5335	1.57%	5/13/2014	5/15/2014	5/27/2014
5/14/2013	annual	$0.4904	1.42%	5/14/2013	5/16/2013	5/28/2013

(Data available from 1/1/2013 forward)

Fresenius Medical Care (NYSE FMS) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 2.48%

Insider Trading History for Fresenius Medical Care (NYSE:FMS)

Institutional Ownership by Quarter for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE FMS) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details

(Data available from 1/1/2013 forward)

Fresenius Medical Care (NYSE FMS) News Headlines

Source:

Date	Headline
	Fresenius Medical Care (FMS) Receives Consensus Rating of "Hold" from Brokerages www.americanbankingnews.com - May 20 at 5:30 PM
	Fresenius Medical Care (FMS) Investor Presentation - Slideshow seekingalpha.com - May 18 at 4:07 PM
	Fresenius Medical Care Sees Continued Strong Growth; AGM Okays Dividend Increase www.nasdaq.com - May 17 at 10:16 AM
	Fresenius Medical Care (FMS) Declares $0.44 Annual Dividend www.americanbankingnews.com - May 16 at 11:16 AM
	Here's Why You Should Sell Fresenius Medical (FMS) Stock Now finance.yahoo.com - May 14 at 4:02 PM
	Here's Why You Should Sell Fresenius Medical (FMS) Stock Now www.zacks.com - May 14 at 11:00 AM
	Comparing Caladrius Biosciences (CLBS) & Fresenius Medical Care (FMS) www.americanbankingnews.com - May 12 at 5:11 PM
	Fresenius Medical Care (FMS) Downgraded by Zacks Investment Research www.americanbankingnews.com - May 9 at 5:12 PM
	Fresenius Medical (FMS) Misses on Q1 Earnings, Lowers View www.zacks.com - May 9 at 10:00 AM
	Catasys (CATS) and Fresenius Medical Care (FMS) Head-To-Head Review www.americanbankingnews.com - May 8 at 12:48 PM
	Fresenius Medical Care (FMS) Issues Earnings Results, Misses Estimates By $0.21 EPS www.americanbankingnews.com - May 5 at 4:54 PM
	Edited Transcript of FME.DE earnings conference call or presentation 3-May-18 1:30pm GMT finance.yahoo.com - May 5 at 10:16 AM
	Fresenius Medical Care (FMS) Receives "Neutral" Rating from Royal Bank of Canada www.americanbankingnews.com - May 4 at 12:21 AM
	Fresenius Medical Care Q1 Profit Down 10%; Affirms FY18 Outlook - Quick Facts www.nasdaq.com - May 3 at 9:49 AM
	Here's Why Akorn Inc Fell as Much as 16.4% Today finance.yahoo.com - May 2 at 4:06 PM
	RenalSense Announces Distribution Agreement With Fresenius Medical Care finance.yahoo.com - April 30 at 10:12 AM
	Jefferies Group Weighs in on Fresenius Medical Care's FY2018 Earnings (FMS) www.americanbankingnews.com - April 30 at 3:44 AM
	Equities Analysts Issue Forecasts for Fresenius Medical Care's FY2021 Earnings (FMS) www.americanbankingnews.com - April 27 at 11:14 AM
	Reviewing Tivity Health (TVTY) and Fresenius Medical Care (FMS) www.americanbankingnews.com - April 26 at 11:35 AM
	Contrasting Catasys (CATS) & Fresenius Medical Care (FMS) www.americanbankingnews.com - April 26 at 8:04 AM
	Fresenius Medical Care (FMS) to Release Quarterly Earnings on Thursday www.americanbankingnews.com - April 26 at 2:50 AM
	Fresenius Medical Care (FMS) Given Consensus Recommendation of "Buy" by Brokerages www.americanbankingnews.com - April 25 at 5:30 PM
	Fresenius Medical Care (FMS) Upgraded to Buy at Deutsche Bank www.americanbankingnews.com - April 24 at 9:12 AM
	Jilted Akorn sues Fresenius over deal termination finance.yahoo.com - April 23 at 4:02 PM
	Fresenius Medical Care (FMS) Stock Rating Reaffirmed by DZ Bank www.americanbankingnews.com - April 23 at 8:12 AM
	Fresenius Medical cuts 2018 sales target after drug dosage shift finance.yahoo.com - April 22 at 4:38 PM
	Fresenius Medical Care's (FMS) "Sell" Rating Reaffirmed at UBS www.americanbankingnews.com - April 20 at 12:58 AM
	Fresenius Medical Care (FMS) Lifted to "Buy" at Zacks Investment Research www.americanbankingnews.com - April 19 at 12:02 PM
	Fresenius Medical Care (FMS) Downgraded by BidaskClub to Buy www.americanbankingnews.com - April 16 at 8:40 PM
	Fresenius Medical Care (FMS) Downgraded to Hold at BidaskClub www.americanbankingnews.com - April 14 at 10:53 PM
	Royal Bank of Canada Reaffirms Neutral Rating for Fresenius Medical Care (FMS) www.americanbankingnews.com - April 12 at 9:35 PM
	Here's Why You Should Invest in Fresenius Medical Right Now finance.yahoo.com - April 10 at 10:24 AM
	Fresenius Medical Care (FMS) Stock Rating Lowered by Zacks Investment Research www.americanbankingnews.com - April 8 at 10:49 AM
	DZ Bank Reiterates Buy Rating for Fresenius Medical Care (FMS) www.americanbankingnews.com - April 5 at 12:26 PM
	Fresenius Medical Care AG & Co. (FMS) Given Consensus Recommendation of "Buy" by Analysts www.americanbankingnews.com - March 31 at 5:42 PM
	Fresenius Medical Care AG & Co. (FMS) Stock Rating Reaffirmed by Nord/LB www.americanbankingnews.com - March 31 at 1:34 PM
	Can Fresenius Medical Care AG & Co KGaA (ETR:FME) Continue To Outperform Its Industry? finance.yahoo.com - March 29 at 4:01 PM
	Fresenius Medical Care AG & Co. (FMS) Stock Rating Reaffirmed by Royal Bank of Canada www.americanbankingnews.com - March 24 at 11:12 PM
	Does Fresenius Medical Care AG & Co KGaA’s (ETR:FME) PE Ratio Signal A Buying Opportunity? finance.yahoo.com - March 20 at 3:56 PM
	3 Favorable Trends Dispelling Tax-Repeal Worries in MedTech finance.yahoo.com - March 20 at 3:56 PM
	Fresenius Medical (FMS) Q4 Earnings Beat, View Impressive finance.yahoo.com - March 8 at 4:42 PM
	Fresenius Medical Care AG & Co. (FMS) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - March 8 at 8:40 AM
	Fresenius Medical Care AG & Co. (FMS) Receives Average Recommendation of "Hold" from Analysts www.americanbankingnews.com - March 6 at 5:26 PM
	Fresenius Medical Care AG & Co. (FMS) Shares Bought by Suntrust Banks Inc. www.americanbankingnews.com - March 3 at 9:56 AM
	Acadia Healthcare (ACHC) and Fresenius Medical Care AG & Co. (FMS) Head-To-Head Review www.americanbankingnews.com - March 2 at 1:16 AM
	The Providence Service (PRSC) versus Fresenius Medical Care AG & Co. (FMS) Financial Review www.americanbankingnews.com - March 1 at 9:14 PM
	Fresenius Medical Care AG & Co. (FMS) Earns Buy Rating from DZ Bank www.americanbankingnews.com - February 28 at 4:34 PM
	Bbva Compass Bancshares Inc. Reduces Position in Fresenius Medical Care AG & Co. (FMS) www.americanbankingnews.com - February 28 at 5:02 AM
	Fresenius Medical Care AG & Co. (FMS) Posts Earnings Results, Beats Expectations By $0.57 EPS www.americanbankingnews.com - February 27 at 5:32 PM
	Fresenius posts 4Q profit www.cnbc.com - February 27 at 4:36 PM

Fresenius Medical Care (NYSE:FMS) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Fresenius Medical Care (NYSE:FMS) Income Statement, Balance Sheet and Cash Flow Statement

Fresenius Medical Care (NYSE FMS) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff